{"id":949688,"date":"2026-04-07T18:53:53","date_gmt":"2026-04-07T22:53:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/"},"modified":"2026-04-07T18:53:53","modified_gmt":"2026-04-07T22:53:53","slug":"medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/","title":{"rendered":"MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit \u2013 RGRD Law"},"content":{"rendered":"
\n

SAN DIEGO, April 07, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP<\/strong><\/a> announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the \u201cClass Period\u201d), have until June 8, 2026 to seek appointment as lead plaintiff of the Medpace <\/em>class action lawsuit. Captioned Durbin v. Medpace Holdings Inc.<\/em>, No. 26-cv-00346 (S.D. Ohio), the Medpace <\/em>class action lawsuit charges Medpace and certain of Medpace\u2019s top executives with violations of the Securities Exchange Act of 1934.<\/p>\n

\n If you suffered substantial losses and wish to serve as lead plaintiff of the <\/strong>
\n
\n Medpace <\/em>
\n <\/strong>
\n class action lawsuit, please provide your information here:<\/strong>\n <\/p>\n

\n
\n https:\/\/www.rgrdlaw.com\/cases-medpace-holdings-inc-class-action-lawsuit-medp.html<\/strong>
\n <\/a>\n <\/p>\n

\n You can also contact attorneys <\/strong>
\n
\n Ken Dolitsky<\/strong>
\n <\/a>
\n or <\/strong>
\n
\n Michael Albert<\/strong>
\n <\/a>
\n of Robbins Geller by calling 800\/449-4900 or via e-mail at <\/strong>
\n
\n info@rgrdlaw.com<\/strong>
\n <\/a>
\n .<\/strong>\n <\/p>\n

\n CASE ALLEGATIONS<\/strong>: Medpace is a clinical contract research organization (CRO) focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries.<\/p>\n

The Medpace <\/em>class action lawsuit alleges that defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: (i) Medpace consistently oversold Medpace\u2019s projected book-to-bill ratio for fourth quarter 2025; (ii) Medpace knew or recklessly disregarded the impact that cancellations have on Medpace\u2019s book-to-bill ratio; (iii) Medpace frequently claimed that the projection of a 1.15 book-to-bill ratio for fourth quarter 2025 was reasonable and achievable and that cancellations were not a sign of a weak business environment; (iv) Medpace reassured investors that Medpace was not concerned about the lack of diversity in its pre-backlog; and (v) Medpace management stated that, despite the uptick in metabolic growth, Medpace\u2019s upside was broad-based and not isolated to any handful of studies.<\/p>\n

The Medpace <\/em>class action lawsuit further alleges that on February 9, 2026, Medpace released fourth quarter 2025 earnings results revealing a book-to-bill ratio of 1.04, well below Medpace\u2019s guidance. On this news, the price of Medpace common stock fell nearly 16%, according to the complaint.<\/p>\n

\n THE LEAD PLAINTIFF PROCESS<\/strong>: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Medpace common stock during the Class Period to seek appointment as lead plaintiff in the Medpace <\/em>class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Medpace <\/em>class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Medpace <\/em>class action lawsuit. An investor\u2019s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Medpace <\/em>class action lawsuit.<\/p>\n

\n ABOUT ROBBINS GELLER: <\/strong>Robbins Geller Rudman & Dowd LLP is one of the world\u2019s leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors \u2013 $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs\u2019 firms in the world, and the Firm\u2019s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever \u2013 $7.2 billion \u2013 in In re Enron Corp. Sec. Litig.<\/em> Please visit the following page for more information:<\/p>\n

\n
\n https:\/\/www.rgrdlaw.com\/services-litigation-securities-fraud.html<\/strong>
\n <\/a>\n <\/p>\n

Past results do not guarantee future outcomes.\u00a0
Services may be performed by attorneys in any of our offices.\u00a0<\/p>\n

Contact:
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Robbins Geller Rudman & Dowd LLP
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Ken Dolitsky
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Michael Albert
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0655 W. Broadway, Suite 1900, San Diego, CA 92101
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0800-449-4900
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0info@rgrdlaw.com<\/strong><\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO, April 07, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the \u201cClass Period\u201d), have until June 8, 2026 to seek appointment as lead plaintiff of the Medpace class action lawsuit. Captioned Durbin v. Medpace Holdings Inc., No. 26-cv-00346 (S.D. Ohio), the Medpace class action lawsuit charges Medpace and certain of Medpace\u2019s top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Medpace class action lawsuit, please provide your information here: https:\/\/www.rgrdlaw.com\/cases-medpace-holdings-inc-class-action-lawsuit-medp.html You can also contact attorneys Ken Dolitsky or … <\/p>\n

Continue reading “MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit \u2013 RGRD Law”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-949688","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit \u2013 RGRD Law - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit \u2013 RGRD Law - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, April 07, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the \u201cClass Period\u201d), have until June 8, 2026 to seek appointment as lead plaintiff of the Medpace class action lawsuit. Captioned Durbin v. Medpace Holdings Inc., No. 26-cv-00346 (S.D. Ohio), the Medpace class action lawsuit charges Medpace and certain of Medpace\u2019s top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Medpace class action lawsuit, please provide your information here: https:\/\/www.rgrdlaw.com\/cases-medpace-holdings-inc-class-action-lawsuit-medp.html You can also contact attorneys Ken Dolitsky or … Continue reading "MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit \u2013 RGRD Law"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-07T22:53:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTgxMCM3NTI0NDA0IzIxMzY1Nzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit \u2013 RGRD Law\",\"datePublished\":\"2026-04-07T22:53:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\\\/\"},\"wordCount\":649,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTgxMCM3NTI0NDA0IzIxMzY1Nzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\\\/\",\"name\":\"MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit \u2013 RGRD Law - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTgxMCM3NTI0NDA0IzIxMzY1Nzk=\",\"datePublished\":\"2026-04-07T22:53:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTgxMCM3NTI0NDA0IzIxMzY1Nzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTgxMCM3NTI0NDA0IzIxMzY1Nzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit \u2013 RGRD Law\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit \u2013 RGRD Law - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/","og_locale":"en_US","og_type":"article","og_title":"MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit \u2013 RGRD Law - Market Newsdesk","og_description":"SAN DIEGO, April 07, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the \u201cClass Period\u201d), have until June 8, 2026 to seek appointment as lead plaintiff of the Medpace class action lawsuit. Captioned Durbin v. Medpace Holdings Inc., No. 26-cv-00346 (S.D. Ohio), the Medpace class action lawsuit charges Medpace and certain of Medpace\u2019s top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Medpace class action lawsuit, please provide your information here: https:\/\/www.rgrdlaw.com\/cases-medpace-holdings-inc-class-action-lawsuit-medp.html You can also contact attorneys Ken Dolitsky or … Continue reading \"MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit \u2013 RGRD Law\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-07T22:53:53+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTgxMCM3NTI0NDA0IzIxMzY1Nzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit \u2013 RGRD Law","datePublished":"2026-04-07T22:53:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/"},"wordCount":649,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTgxMCM3NTI0NDA0IzIxMzY1Nzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/","name":"MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit \u2013 RGRD Law - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTgxMCM3NTI0NDA0IzIxMzY1Nzk=","datePublished":"2026-04-07T22:53:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTgxMCM3NTI0NDA0IzIxMzY1Nzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTgxMCM3NTI0NDA0IzIxMzY1Nzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-investor-alert-medpace-holdings-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-medpace-class-action-lawsuit-rgrd-law\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit \u2013 RGRD Law"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949688","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=949688"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949688\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=949688"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=949688"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=949688"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}